The Patent Finder

Terms ending in 2039

Purdue Pharma L.P.

Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,576,913Sleep Disorder Treatment and Prevention
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 12,171,762Sleep Disorder Treatment and Prevention
In force
 · Low confidence
Knoa Pharma LLCIn forceLow confidence
US 11,401,345Humanized Antibodies Targeting Human Tissue Factor
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 11,576,899Tinostamustine for Use in Treating Sarcoma
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 12,161,754Abuse Deterrent Morphine Sulfate Dosage Forms
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 11,857,547Compositions and Methods for Opioid Antagonist Delivery
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 11,865,112Compositions and Methods for Opioid Antagonist Delivery
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Purdue Pharma L.P..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited